Patterns of failure in cases of carcinoma of esophagus treated with radical concurrent chemoradiation
Journal Title: International Journal of Medical Research and Review - Year 2016, Vol 4, Issue 5
Abstract
Background: Radical chemoradiation has been the main stay of treatment in inoperable cases of carcinoma of thoracic oesophagus. The purpose of the study is to determine the pattern of recurrence after radical concurrent chemoradiation. Materials and Methods: Fifty patients with carcinoma esophagus treated with chemoradiation were taken retrospectively for this study. All the patients were treated with external beam radiation therapy (3DCRT/IMRT) of 54 to 59.4Gy with 3 weekly cisplatin 80 mg/m2 and capicitabine 1250 mg /m2. All patients were followed with upper GI endoscopy at 3-4 monthly for first 3 years, CECT thorax and abdomen at every 3 month for 1 year then 6 monthly up to 3 year thereafter yearly follow up. Appropriate statistics were used for the analysis. All the patient information was taken out from the case files and by telephonic interview. Results: 50 patients were included in the retrospective analysis. Median age was 54 years. 26 (52%) were males and 24 (48%) were females. Most common tumour histology being squamous cell carcinoma and most common site being the middle 1/3 of esophagus 30/50(60%). 47/50 (94%) patients received concurrent chemoradiation with cisplatin with capecitabine and 3/50 (6%) received induction chemotherapy with cisplatin and 5-FU. Patients were followed up for a period of 8 months to 34 months (median: 21 months). At the time of last follow up in September 2015, 23/50(46%) patients had local recurrence, 14 (28%) patients had distant failure and 13(26%) patients had no evidence of disease at the time of last follow up. With a median follow up of 21 months, mean overall survival for all the patients was 17.5 months. Patients surviving at the end of 1 year were 68%, at 2 years was 36%, and at 3 years was 4.3%. Conclusion: This study concludes that highest incidence of failure and recurrences occur most commonly locally (within the previously irradiated field) even after definitive radical treatment with concurrent chemoradiation. As the local recurrence is more than distant failure we should aim at consolidating the local therapy by dose escalation or alternative radiation therapy.
Authors and Affiliations
Naveen T, Naveen T,, Ibrahim Khaleel, Lalit Kashyap, Surekha Goyal, Govardhan HB, Siddanna P Sridhar, KPR Pramod KPR Pramod, Nivedita Sarkar, Sathish A
Keywords
Related Articles
- EP ID EP230089
- DOI 10.17511
- Views 169
- Downloads 0
The relationship between blood sugar levels (glycosylated haemoglobin) and the risk of development of diabetic retinopathy
Introduction: Diabetic retinopathy is a major cause of visual impairment and blindness in India and with its early detection and timely treatment, the risk of visual loss can be reduced significantly. Onset and progressi...
Rare Entities of Mixed Phenotypic Acute Leukemia: Are They Really So Rare? Largest Series of B+T MPAL
Background: MPAL are rare, accounts 4% of acute leukemias. B+T MPAL are extremely rare. There is no robust information on the clinical and biologic features of these leukemias. Present study from kidwai memorial institut...
Phenotypic characterization of Trichosporon species from clinical isolates
Introduction: Trichosporon spp. arepresent as normal flora of skin and perigenital area in humans. They can cause invasive trichosporonosis in immuno-compromised individuals. Trichosporon infections are difficult to trea...
Study of clinical profile of tuberculosis in HIV infected patients with special reference to CD4 T cell count and its oral manifestation
Aim: To study the clinical profile of tuberculosis in HIV infected patients and to compare the different clinical data with their CD4 counts with reference to oral health. Material Methods: Total 100 cases attending Depa...
Additive effect of butorphanol in supraclavicular brachial plexus block
Introduction: Increasing the quality of regional anaesthesia has always been an area of interest for anaesthesiologist. Butorphanol is a synthetic opioid analgesic having partial agonist at μ & agonistic activity at kapp...